145 related articles for article (PubMed ID: 12351404)
1. Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells.
Sakai I; Takeuchi K; Yamauchi H; Narumi H; Fujita S
Blood; 2002 Oct; 100(8):2926-31. PubMed ID: 12351404
[TBL] [Abstract][Full Text] [Related]
2. Expression of SOCS3 mRNA in bone marrow cells from CML patients associated with cytogenetic response to IFN-alpha.
Takeuchi K; Sakai I; Narumi H; Yasukawa M; Kojima K; Minamoto Y; Fujisaki T; Tanimoto K; Hara M; Numata A; Gondo H; Takahashi M; Fujii N; Masuda K; Fujita S
Leuk Res; 2005 Feb; 29(2):173-8. PubMed ID: 15607366
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of IFN-alpha inducible genes in human chronic myelogenous leukemia cell line KT-1].
Takeuchi K
Rinsho Ketsueki; 2003 Feb; 44(2):65-9. PubMed ID: 12692977
[No Abstract] [Full Text] [Related]
4. The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha.
Roman-Gomez J; Jimenez-Velasco A; Castillejo JA; Cervantes F; Barrios M; Colomer D; Heiniger A; Torres A
Haematologica; 2004 Jan; 89(1):42-8. PubMed ID: 14754605
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to interferon-alpha and interferon-stimulated gene factor 3 binding activity in human chronic myelogenous leukemia cell line KT-1.
Yamauchi H; Sakai I; Narumi H; Soga S; Fujita S
Acta Haematol; 2000; 104(1):1-9. PubMed ID: 11111114
[TBL] [Abstract][Full Text] [Related]
6. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
[TBL] [Abstract][Full Text] [Related]
7. Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha.
Yanagisawa K; Yamauchi H; Kaneko M; Kohno H; Hasegawa H; Fujita S
Blood; 1998 Jan; 91(2):641-8. PubMed ID: 9427720
[TBL] [Abstract][Full Text] [Related]
8. Induction of interferon regulatory factors 2'-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness.
Fischer T; Aman J; van der Kuip H; Rudolf G; Peschel C; Aulitzky WE; Huber C
Br J Haematol; 1996 Mar; 92(3):595-603. PubMed ID: 8616023
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
10. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
11. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
[TBL] [Abstract][Full Text] [Related]
12. Upregulated production of IL-6, but not IL-10, by interferon-alpha induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells.
Usui E; Nishii K; Katayama N; Lorenzo V F; Chen F; Monma F; Otsuki T; Shiku H
Hematol J; 2004; 5(6):505-12. PubMed ID: 15570293
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
[TBL] [Abstract][Full Text] [Related]
14. [Detection of SOCS-1 mRNA expression by RT-PCR in the patients with myeloid leukemia].
Yang HP; Dai M; Zhou HS; Huang L; Zhang DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):677-80. PubMed ID: 16928298
[TBL] [Abstract][Full Text] [Related]
15. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells.
Yu CR; Mahdi RM; Ebong S; Vistica BP; Gery I; Egwuagu CE
J Biol Chem; 2003 Aug; 278(32):29752-9. PubMed ID: 12783879
[TBL] [Abstract][Full Text] [Related]
17. Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia.
Hochhaus A; Yan XH; Willer A; Hehlmann R; Gordon MY; Goldman JM; Melo JV
Leukemia; 1997 Jul; 11(7):933-9. PubMed ID: 9204971
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of therapeutic effects of low-dose versus high-dose interferon alpha-2b treatment on chronic myelocytic leukemia: a prospective randomized study].
Du JW; Zhu P; Tian D; Dong ZR; Yang SL; Li SB; Tang YH; Liu H; Cen XN; Zhang Y; Zhu Q; Zhu YL; Yang Y; Wang DX; Wang Z; Cui H; Ma YG; Chen WM; Liu FQ; Ma J; Wang JW; Shen T; Da WM
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1305-9. PubMed ID: 16029627
[TBL] [Abstract][Full Text] [Related]
19. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3.
Shen X; Hong F; Nguyen VA; Gao B
FEBS Lett; 2000 Sep; 480(2-3):132-6. PubMed ID: 11034314
[TBL] [Abstract][Full Text] [Related]
20. The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia.
Tanaka M; Yamazaki Y; Hattori M; Tsushita K; Utsumi M; Yoshida S
Leuk Res; 1996 Jul; 20(7):575-80. PubMed ID: 8795691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
